August 4, 2016
This morning FLG client Inspyr Therapeutics (OTCQB: NSPX, formerly known as GenSpera, Inc.) announced the appointment of FLG partner Chris Lowe as its CEO. Company press release.
Enter your email address below to receive updates from FLG Partners.
This morning FLG client Inspyr Therapeutics (OTCQB: NSPX, formerly known as GenSpera, Inc.) announced the appointment of FLG partner Chris Lowe as its CEO. Company press release.